ANIMAL MODELS OF REDOX METABOLISM AND ARTERIAL DYSFUNCTION

$210,714P01FY2013HLNIH

Brigham And Women'S Hospital, Boston MA

Investigators

Linked publications & trials

Paper 37942611 Paper 31852220 Paper 30279532 Paper 29899023 Paper 29444854 Paper 29244159 Paper 28917508 Paper 27940350 Paper 27920522 Paper 27548520 Paper 27362337 Paper 27278246 Paper 27230637 Paper 27004607 Paper 26985825 Paper 26898714 Paper 26868210 Paper 26744461 Paper 26586488 Paper 26543094 Paper 26506125 Paper 26481668 Paper 26379338 Paper 26295369 Paper 26212716 Paper 26176386 Paper 26034041 Paper 25955212 Paper 25911613 Paper 25824145 Paper 25799144 Paper 25782777 Paper 25650558 Paper 25530704 Paper 25263595 Paper 25185259 Paper 25170063 Paper 25095746 Paper 25064526 Paper 25006435 Paper 25001622 Paper 24862275 Paper 24843047 Paper 24719327 Paper 24630946 Paper 24561125 Paper 24550450 Paper 24498385 Paper 24315787 Paper 24265198 Paper 24153306 Paper 24111795 Paper 24059347 Paper 24004503 Paper 23955381 Paper 23951127 Paper 23911322 Paper 23901139 Paper 23849859 Paper 23833290 Paper 23817482 Paper 23812841 Paper 23809160 Paper 23806663 Paper 23769208 Paper 23751938 Paper 23723371 Paper 23712003 Paper 23434902 Paper 23316327 Paper 23212105 Paper 23137497 Paper 23130098 Paper 23111998 Paper 23097236 Paper 23015643 Paper 22970272 Paper 22935211 Paper 22934846 Paper 22927471 Paper 22927426 Paper 22821909 Paper 22787113 Paper 22773836 Paper 22770551 Paper 22607099 Paper 22581565 Paper 22561685 Paper 22555438 Paper 22520962 Paper 22435680 Paper 22412087 Paper 22382498 Paper 22371328 Paper 22294708 Paper 22293227 Paper 22293023 Paper 22227328 Paper 22201682 Paper 22147691

Abstract

Overview and Specific Aims Core B will provide support for all four Projects by 1) performing vascular physiology and pharmacology experiments in the transgenic and knockout mouse models being investigated in this PPG, and 2) by coordinating the proposed studies with the Yale Mouse Metabolic Phenotyping Center (YMMC) for the detailed in vivo metabolic characterizations that are planned for several ofthe mouse models being studied in this Program. The proposed studies of mouse vascular physiology and metabolism being supported in this Core will provide a critical context for the data that will be generated by Program's proposed Common Experiment, which explores redox biochemistry and redox biomarkers in mouse endothelial cells. Dr. Michel, who has served as Director of the Animal Models of Arterial Dysfunction Core Lab during the current project period, is an experienced vascular biologist who has been involved in productive collaborations studying murine vascular physiology and pharmacology with the pther Project Leaders. Dr. Gerald Shulman (see attached letter), a leading investigator in metabolism, is the director of the YMMC, and is already collaborating with Drs. Plutzky and Lee; Dr. Shulman will continue to consult on experimental design and analysis in the proposed studies, which are described in detail in all the individual Project descriptions above.

View original record on NIH RePORTER →